News Chart Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 20:52:04 17/06/2025 BST			5-day change	1st Jan Change
15.46 ^USD	-1.53%		-6.34%	-17.45%

06-09	Arrowhead Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 02:00 PM
06-02	Arrowhead Pharmaceuticals Initiates Phase 1/2A Study of Aro-Alk7 for the Treatment of Obesity	CI

ac8f84aa741a72eaa121abe97fe11d6.nlTGJFXDv7E0B0ShosBFyCKD-aUAOLLpOkj2wcKTdEQ.23mUUGCL_Od5SXLlk4Zygn3KuNA0CcGMQiOHno__OXzRF4dgPrOS1HJVCQ~c682567b0c0bfc27cf5c0868657f713b